SCHEMBL20041861

SCHEMBL20041861

CC(C)C(O)C1CCN(C)C1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22479915 0.88 CACNA2D1 (0.35)
SCHEMBL22951415 0.86 NCF1 (0.34) NCF1
SCHEMBL7513512 0.82
SCHEMBL24723652 0.81
SCHEMBL17518799 0.81 NCF1 (0.31) NCF1
SCHEMBL8504951 0.79
SCHEMBL22024815 0.77 NCF1 (0.34) NCF1
SCHEMBL24644279 0.77 NCF1 (0.34) NCF1
SCHEMBL26424563 0.77 NCF1 (0.31) NCF1
SCHEMBL13006548 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2454234-B1 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS THERAVANCE BIOPHARMA R&D IP LLC (US) 2018-04-11 EP disclosed